Literature DB >> 19266607

Intrahepatic cholestasis of pregnancy: when should you look further?

Winita Hardikar1, Shivani Kansal, Ronald P J Oude Elferink, Peter Angus.   

Abstract

Pruritus with abnormal liver function tests is the classical presentation of intrahepatic cholestasis of pregnancy (ICP), a condition associated with significant fetal complications. Although the etiology of ICP is unclear in many cases, certain features of the clinical presentation should alert the practitioner to the possibility of an underlying metabolic defect, which may not only affect subsequent pregnancies, but may be an indicator of more serious subsequent liver disease. We report a kindred of Anglo-Celtic descent, among whom many members present with ICP, gallstones or cholestasis related to use of oral contraception. Genetic studies revealed a novel mutation in the ABCB4 gene, which codes for a phospholipid transport protein. The clinical significance of this mutation and the importance of identifying such patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266607      PMCID: PMC2655184          DOI: 10.3748/wjg.15.1126

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

Review 1.  Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

Authors:  Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Pflugers Arch       Date:  2006-04-19       Impact factor: 3.657

2.  Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.

Authors:  G Mazzella; N Rizzo; F Azzaroli; P Simoni; L Bovicelli; A Miracolo; G Simonazzi; A Colecchia; G Nigro; C Mwangemi; D Festi; E Roda; R Nicola; A Francesco; S Patrizia; B Luciano; M Anna; S Giuliana; C Antonio; N Giovanni; M Constance; F Davide; R Enrico
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 3.  Diagnosis and therapy of intrahepatic cholestasis of pregnancy.

Authors:  T C Paus; G Schneider; P Van De Vondel; T Sauerbruch; C Reichel
Journal:  Z Gastroenterol       Date:  2004-07       Impact factor: 2.000

4.  Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment.

Authors:  Piotr Milkiewicz; Ruth Gallagher; Jenny Chambers; Enid Eggington; Judith Weaver; Elwyn Elias
Journal:  J Gastroenterol Hepatol       Date:  2003-11       Impact factor: 4.029

Review 5.  Liver disease in pregnancy.

Authors:  J Eileen Hay
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

6.  Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy.

Authors:  A Floreani; I Carderi; D Paternoster; G Soardo; F Azzaroli; W Esposito; M Montagnani; D Marchesoni; A Variola; E Rosa Rizzotto; C Braghin; G Mazzella
Journal:  Dig Liver Dis       Date:  2007-12-20       Impact factor: 4.088

Review 7.  Intrahepatic cholestasis of pregnancy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Orphanet J Rare Dis       Date:  2007-05-29       Impact factor: 4.123

Review 8.  Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene.

Authors:  Olivier Rosmorduc; Raoul Poupon
Journal:  Orphanet J Rare Dis       Date:  2007-06-11       Impact factor: 4.123

  8 in total
  6 in total

1.  First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.

Authors:  Eric Pasmant; Philippe Goussard; Laetitia Baranes; Ingrid Laurendeau; Samuel Quentin; Philippe Ponsot; Yann Consigny; Olivier Farges; Bertrand Condat; Dominique Vidaud; Michel Vidaud; Jian-Min Chen; Béatrice Parfait
Journal:  Eur J Hum Genet       Date:  2011-10-12       Impact factor: 4.246

2.  Analysis of mutations of MDR3 exons 9 and 23 in infants with parenteral nutrition-associated cholestasis.

Authors:  Xiu-Fang Yang; Guo-Sheng Liu; Min-Xu Li
Journal:  Exp Ther Med       Date:  2015-10-14       Impact factor: 2.447

3.  Development and Validation of a Dynamic Nomogram to Predict the Risk of Neonatal White Matter Damage.

Authors:  Wenjun Cao; Chenghan Luo; Mengyuan Lei; Min Shen; Wenqian Ding; Mengmeng Wang; Min Song; Jian Ge; Qian Zhang
Journal:  Front Hum Neurosci       Date:  2021-02-23       Impact factor: 3.169

4.  Mdr3 gene mutation in preterm infants with parenteral nutrition-associated cholestasis.

Authors:  Xiufang Yang; Guosheng Liu; Bing Yi
Journal:  Mol Genet Genomic Med       Date:  2022-02-12       Impact factor: 2.183

5.  Norethisterone-induced cholestasis: A case report.

Authors:  Safa Moussaoui; Mehdi Abdelwahed; Nabil Ben Chaaben; Ahlem Bellalah; Najah Ben Fadhel; Arwa Guediche; Mejda Zakhama; Ramzi Tababi; Karim Aouam; Zakhama Abdelfattah; Hichem Loghmari; Leila Safer
Journal:  Clin Case Rep       Date:  2022-03-03

6.  Correlation between mutation of MDR3 gene exon 6 and parenteral nutrition-associated cholestasis of preterm infants.

Authors:  Xiu Fang Yang; Guo Sheng Liu; Bing Yi
Journal:  Exp Ther Med       Date:  2014-09-19       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.